Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
antiviral drug sulfonamide antibiotic |
| gptkbp:ATCCode |
P01BD06
|
| gptkbp:CASNumber |
2447-57-6
|
| gptkbp:contraindication |
sulfonamide allergy
|
| gptkbp:discoveredIn |
1960s
|
| gptkbp:eliminationHalfLife |
7 to 9 days
|
| gptkbp:hasMolecularFormula |
C12H14N4O4S
|
| gptkbp:hasSMILES |
COc1cnc(NC2=CC=C(C=C2)S(=O)(=O)N)c(OC)n1
|
| gptkbp:hasUNII |
8Y164V895Y
|
| https://www.w3.org/2000/01/rdf-schema#label |
sulfadoxine
|
| gptkbp:IUPACName |
4-amino-N-(5,6-dimethoxy-4-pyrimidinyl)benzenesulfonamide
|
| gptkbp:KEGGID |
D08541
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:listedOn |
gptkb:WHO_Model_List_of_Essential_Medicines
|
| gptkbp:molecularWeight |
310.33 g/mol
|
| gptkbp:partOf |
gptkb:Fansidar
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL137
5326 DB01299 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
gptkb:Stevens-Johnson_syndrome
allergic reaction rash |
| gptkbp:usedFor |
pyrimethamine
treatment of malaria |
| gptkbp:bfsParent |
gptkb:sulfadoxine-pyrimethamine
|
| gptkbp:bfsLayer |
6
|